Richard Day of the University of New South Wales, writing in the October 2023 edition of DIA’s Global Forum magazine, looks at updates to the health…

After last year’s acquisition of Vifor Pharma, the firm’s largest ever, opened new avenues for diversification, the ground-breaking approval of…

CSL, Australia’s largest biopharma company, overcame the challenges of the pandemic-related decline in plasma collection and has since racked up…

A roundup of some of the latest news from Australian pharma, including CSL’s unification of business units, a workers strike at Pfizer’s…

With one of the best healthcare systems in the world, according to the World Health Organisation (WHO), Australia is home to some 250 global and local…

Writing in the June edition of DIA’s Global Forum magazine, Ellen Sem, Fengyun (Vicky) Han and Annetta C. Beauregard from Janssen Pharmaceutical…

Pharmaceutical policy issues played a major role in Australia’s recent national election. Shawview Consulting’s Brendan Shaw outlines the…

Writing in April edition of DIA's Global Forum magazine, the University of New South Wales’s Richard Day looks at Australia’s National Medicines…

Writing in the January edition of DIA’s Global Forum magazine, Julia Chan, David Liew, Jana Stojanova, and Chris McMaster of Austin Health,…

Australia's international outlook, strong science base, multi-ethnic English-speaking population and high educational and regulatory standards make it…

In conversation in the November issue of DIA’s Global Forum magazine, Australian Pharmaceutical medical and scientific Professionals Association…

As our thoughts here at PharmaBoardroom turn towards the summer holidays, we are happy to share the five most-read articles from our global…